Emily Simonoff

Last updated

Emily Simonoff is Professor of Child and Adolescent Psychiatry in the Child and Adolescent Mental Health Services (CAMHS) Neuropsychiatry Service, head of the Child and Adolescent Psychiatry department at the Institute of Psychiatry and lead for the CAMHS Clinical Academic Group at King's Health Partners, King's College London. [1] [2]

Contents

Career and research

Simonoff is chair of the Mental Health Research Network for treatment of children with mental health problems and a member of the NICE guideline development group for treatment and diagnosis of autism in children and adolescents. She is on the editorial board of British Journal of Psychiatry. [1]

She is a Fellow of the Royal College of Psychiatrists [3] and a Senior Investigator at the National Institute for Health and Care Research (NIHR). [4]

In February 2025, the National Institute for Health and Care Research (NIHR) revealed that the NHS had commissioned Emily Simonoff to lead a £10.7 million clinical trial on puberty blockers which is planned to last until 2031. [5] [6]

Selected publications

References

  1. 1 2 "Professor Emily Simonoff". National.slam.nhs.uk. Archived from the original on 2014-02-02. Retrieved 2014-01-20.
  2. "Emily Simonoff". KCL. Retrieved 2014-01-20.
  3. "Prof Emily Simonoff". www.slam.nhs.uk. Retrieved 2022-02-10.
  4. "2019 NIHR Senior Investigators appointments announced | Website archive | King's College London". www.kcl.ac.uk. Retrieved 2022-02-10.
  5. Cutler, Georgina (25 February 2025). "NHS to start offering puberty blockers as part of £10m clinical trial despite warnings of 'unethical experiment on children'". GB News. Retrieved 27 May 2025.
  6. Fox, Aine (27 February 2025). "£10m funding for children's gender research including NHS puberty blocker trial". The Independent. Retrieved 27 May 2025.